Tvardi Therapeutics Inc (TVRD)

EBITDA Growth

-129.46%

TTM · Period ending:

TVRD logo

TVRD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-129.46%
TVRD TTM EBITDA YoY % (87.98% → -129.46%)
High-resolution chart · PNG

TVRD ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Tvardi Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-129.4593%
32.1403%
78.5611%
81.1273%
87.9836%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.